Systematic Mutational Analysis of the Receptor-Binding Region of the Human Urokinase-Type Plasminogen Activator-Reference-Cited by-同舟云学术

Systematic Mutational Analysis of the Receptor-Binding Region of the Human Urokinase-Type Plasminogen Activator

Published:1996-05 Issue:3 Volume:237 Page:743-751
ISSN:0014-2956
Container-title:European Journal of Biochemistry
language:en
Short-container-title:Eur J Biochem

Author:

Magdolen Viktor,Rettenberger Peter,Koppitz Marcus,Goretzkt Lothar,Kessler Horst,Weidle Ulrich H.,Konig Bernhard,Graeff Henner,Schmitt Manfred,Wilhelm Olaf

Publisher

Wiley

Subject

Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1432-1033.1996.0743p.x/fullpdf

Reference45 articles.

1. Plasminogen Activators, Tissue Degradation, and Cancer

2. Tumor-Associated Urokinase-Type Plasminogen Activator: Biological and Clinical Significance

3. Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

4. Differential protease expression by cutaneous squamous and basal cell carcinomas.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An engineered ultrahigh affinity bi‐paratopic uPAR targeting agent confers enhanced tumor targeting;Biotechnology and Bioengineering;2024-07-04

2. Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View;Frontiers in Cell and Developmental Biology;2022-04-08

3. Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer;Cancers;2022-01-19

4. The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities;Cancers;2021-10-27

5. Development of AE147 Peptide-Conjugated Nanocarriers for Targeting uPAR-Overexpressing Cancer Cells;International Journal of Nanomedicine;2021-08